Nanomiemgel-a novel drug delivery system for topical application-in vitro and in vivo evaluation J Somagoni, CHA Boakye, C Godugu, AR Patel, HA Mendonca Faria, ... PLoS One 9 (12), e115952, 2014 | 84 | 2014 |
Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment CHA Boakye, K Patel, R Doddapaneni, A Bagde, S Marepally, M Singh Journal of Controlled Release 246, 120-132, 2017 | 79 | 2017 |
Piperlongumine for enhancing oral bioavailability and cytotoxicity of docetaxel in triple-negative breast cancer K Patel, N Chowdhury, R Doddapaneni, CHA Boakye, C Godugu, ... Journal of pharmaceutical sciences 104 (12), 4417-4426, 2015 | 67 | 2015 |
Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques S Marepally, CHA Boakye, AR Patel, C Godugu, R Doddapaneni, ... Nanomedicine 9 (14), 2157-2174, 2014 | 67 | 2014 |
Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers CHA Boakye, K Patel, M Singh International journal of pharmaceutics 489 (1-2), 106-116, 2015 | 61 | 2015 |
Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer K Patel, R Doddapaneni, N Chowdhury, CHA Boakye, G Behl, M Singh Nanomedicine 11 (11), 1377-1392, 2016 | 57 | 2016 |
Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery S Marepally, CHA Boakye, PP Shah, JR Etukala, A Vemuri, M Singh PloS one 8 (12), e82581, 2013 | 56 | 2013 |
Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention CHA Boakye, K Patel, R Doddapaneni, A Bagde, G Behl, N Chowdhury, ... Colloids and Surfaces B: Biointerfaces 143, 156-167, 2016 | 36 | 2016 |
Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis PP Shah, PR Desai, CHA Boakye, R Patlolla, LC Kikwai, RJ Babu, ... Journal of Drug Targeting 24 (6), 537-547, 2016 | 19 | 2016 |
Chemoprevention of skin cancer with 1, 1-Bis (3′-Indolyl)-1-(Aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1) CHA Boakye, R Doddapaneni, PP Shah, AR Patel, C Godugu, S Safe, ... PloS one 8 (8), e69519, 2013 | 19 | 2013 |
Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation CHA Boakye, K Patel, AR Patel, HAM Faria, V Zucolotto, S Safe, M Singh Drug Delivery and Translational Research 6, 526-539, 2016 | 11 | 2016 |
Enhanced percutaneous delivery of 1, 1-bis (3-indolyl)-1-(p-chlorophenyl) methane for skin cancer chemoprevention CHA Boakye, PP Shah, R Doddapaneni, AR Patel, S Safe, M Singh Journal of Biomedical Nanotechnology 11 (7), 1269-1281, 2015 | 8 | 2015 |
Design, Synthesis of Novel Lipids as Chemical Permeation Enhancers and Development of Nanoparticle System for Transdermal Drug Delivery (vol 8, e82581, 2013) S Marepally, CHA Boakye, PP Shah, JR Etukala, A Vemuri PLoS One 9 (4), 2014 | 1 | 2014 |
Nurr1, a novel target of 1, 1-bis (3’-indolyl)-1-(p-chlorophenyl) methane for inhibition of the initiation and progression of skin cancer tumorigenesis R Doddapaneni, C Boakye, P Shah, AR Patel, C Godugu, S Safe, ... Cancer Research 74 (19_Supplement), 3139-3139, 2014 | | 2014 |